-
Study aim
-
determine the effect of photobiomodulation therapy with ۸۱۰ nm Diode laser on the recovery of mid face sensation following maxillary Lefort ۱ surgery
-
Design
-
The clinical trial will be performed as a split face, three-way blind, randomized, phase 3, on 10 patients. Excel random function was used for randomization.
-
Settings and conduct
-
This blind 3-sided clinical trial (patient, examiner and statistical analyst) is performed as a split face on patients aged 18 to 40 years who have referred to Shariati and Sina hospitals of Tehran University of Medical Sciences for Lefort 1 osteotomy. On the intervention side, laser therapy will be performed on days 1, 3, 7, 14, 21 and 28 after the operation. The laser probe on the control side is inactive at similar points and the patient will not know if the laser probe is on or off. All patients will be evaluated for neuroscience with standard sensory tests before and after surgery, as well as on days 1, 3, 7, 14, 21, 28, and 35 in the middle of the face on both sides of the control and intervention.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: No previous maxillofacial trauma , Absence of oral diseases, No uncontrolled systemic diseases
Exclusion criteria: Existence or history of trauma or head and neck malignancies, Pregnancy and lactation, experiencing fractures or obvious nerve damage during surgery, Postoperative infection, Contraindication laser therapy
-
Intervention groups
-
In the middle part of the participants' face, one side is considered as the intervention area and the other side is considered as the control.
Intervention: Laser therapy on days 1, 3, 7, 14, 21 and 28 after surgery
Control: Lack of laser therapy
-
Main outcome variables
-
2point discrimination test
thermal discrimination test
sharp blunt discrimination test
brush stroke directional test
Patient satisfaction level using visual analogue scale